The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Serum TSH, T 4 , and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
Abstract
NHANES III measured serum TSH, total serum T4, antithyroperoxidase (TPOAb), and antithyroglobulin (TgAb) antibodies from a sample of 17,353 people aged ≥12 yr representing the geographic and ethnic distribution of the U.S. population. These data provide a reference for other studies of these analytes in the U.S. For the 16,533 people who did not report thyroid disease, goiter, or taking thyroid medications (disease-free population), we determined mean concentrations of TSH, T4, TgAb, and TPOAb. A reference population of 13,344 people was selected from the disease-free population by excluding, in addition, those who were pregnant, taking androgens or estrogens, who had thyroid antibodies, or biochemical hypothyroidism or hyperthyroidism. The influence of demographics on TSH, T4, and antibodies was examined. Hypothyroidism was found in 4.6% of the U.S. population (0.3% clinical and 4.3% subclinical) and hyperthyroidism in 1.3% (0.5% clinical and 0.7% subclinical). (Subclinical hypothyroidism is used in this paper to mean mild hypothyroidism, the term now preferred by the American Thyroid Association for the laboratory findings described.) For the disease-free population, mean serum TSH was 1.50 (95% confidence interval, 1.46–1.54) mIU/liter, was higher in females than males, and higher in white non-Hispanics (whites) [1.57 (1.52–1.62) mIU/liter] than black non-Hispanics (blacks) [1.18 (1.14–1.21) mIU/liter] (P < 0.001) or Mexican Americans [1.43 (1.40–1.46) mIU/liter] (P < 0.001). TgAb were positive in 10.4 ± 0.5% and TPOAb, in 11.3 ± 0.4%; positive antibodies were more prevalent in women than men, increased with age, and TPOAb were less prevalent in blacks (4.5 ± 0.3%) than in whites (12.3 ± 0.5%) (P < 0.001). TPOAb were significantly associated with hypo or hyperthyroidism, but TgAb were not. Using the reference population, geometric mean TSH was 1.40 ± 0.02 mIU/liter and increased with age, and was significantly lower in blacks (1.18 ± 0.02 mIU/liter) than whites (1.45 ± 0.02 mIU/liter) (P < 0.001) and Mexican Americans (1.37 ± 0.02 mIU/liter) (P < 0.001). Arithmetic mean total T4 was 112.3 ± 0.7 nmol/liter in the disease-free population and was consistently higher among Mexican Americans in all populations. In the reference population, mean total T4 in Mexican Americans was (116.3 ± 0.7 nmol/liter), significantly higher than whites (110.0 ± 0.8 nmol/liter) or blacks (109.4 ± 0.8 nmol/liter) (P < 0.0001). The difference persisted in all age groups. In summary, TSH and the prevalence of antithyroid antibodies are greater in females, increase with age, and are greater in whites and Mexican Americans than in blacks. TgAb alone in the absence of TPOAb is not significantly associated with thyroid disease. The lower prevalence of thyroid antibodies and lower TSH concentrations in blacks need more research to relate these findings to clinical status. A large proportion of the U.S. population unknowingly have laboratory evidence of thyroid disease, which supports the usefulness of screening for early detection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although higher serum TSH values might occur naturally, as part of the ageing process, [15][16][17]”
From Hypothyroidism (2024) · cites this paper as [15]
In the citing paper
“although the NHANES III study identified that the overall prevalence of hypothyroidism was 4•6%.15”
From Hypothyroidism (2024) · cites this paper as [15]
In the citing paper
“The prevalence was markedly lower in individuals of African Caribbean descent (1•7%).15”
From Hypothyroidism (2024) · cites this paper as [15]
In the citing paper
“the distribution of serum TSH reference interval is right -shifted with age, 24 -26 giving an upper 97.5% confidence interval of around 7.5 mU/L in healthy elderly people. 2,3”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [24]
In the citing paper
“This shift in the normal TSH distribution to a higher range in older individuals might represent a normal part of ageing,15-17,131”
From Hypothyroidism (2024) · cites this paper as [15]
In the citing paper
“NHANES III reported the 97•5th percentile for TSH exceeded 7•0 mIU/L in individuals older than 80 years, 15,16 even after exclusion of TPO-Ab-positive individuals”
From Hypothyroidism (2024) · cites this paper as [15]
In the citing paper
“studies in iodine-replete populations without thyroid disease have reported higher TSH concentrations in older individuals.15,17,19,20”
From Hypothyroidism (2024) · cites this paper as [15]
In the citing paper
“The prevalence of SHyper was 0.7% with a cutoff TSH value of <0.1 mIU/l, and 1.8% with a cutoff TSH value of <0.4 mIU/l [10] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [10]
In the citing paper
“Studies in several populations (Americans, Scottish, Ashkenazi Jews, Chinese) have shown progressively increasing TSH concentrations with age.”
From Risks of suboptimal and excessive thyroid hormone replacement across ages (2023) · cites this paper as [32]
In the citing paper
“The 97.5th percentiles of the reference population are considerably higher in the elderly (older than 70 years old) than in younger adults [32–35], which is not explained only by higher prevalence of thyroid autoimmunity [36, 37].”
From Risks of suboptimal and excessive thyroid hormone replacement across ages (2023) · cites this paper as [32]
In the citing paper
“Even though its prevalence has not been precisely documented, non-optimal thyroxine therapy, as evidenced by TSH levels above (or below) the reference range, is common (Table 2)”
From Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report (2017) · cites this paper as [14]
In the citing paper
“In the NHANES III study, median TSH concentrations progressively increased with age and the 97.5th percentiles were considerably higher in the >70 years old reference population without thyroid antibodies (97.5th percentile TSH in the reference population: total 4.1 mU/l; 70–79 yo 5.9 mIU/l; >80 yo 7.5 mU/l) (11).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [11]
In the citing paper
“Convincing evidence during the last decades has shown an age-dependent shift in TSH distribution towards higher concentrations with increasing age.”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [11]
In the citing paper
“Five to 24 percent of all patients taking L-T4 develop iatrogenic thyrotoxicosis (9, 11, 78, 81–83), a proportion that is even higher in the elderly [up to 41% (79)].”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [11]
In the citing paper
“the normal TSH distribution curve is shifted to the right in the elderly (Fig. 1) and it is increasingly recognised that higher TSH levels may represent a normal part of ageing [15–17].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [15]
In the citing paper
“Thyroid stimulating hormone (TSH) concentrations are higher at the extremes of life and show a U-shaped longitudinal trend in iodine sufficient Caucasian populations.”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [15]
In the citing paper
“it is increasingly recognised that higher TSH levels may represent a normal part of ageing [15–17].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [15]
In the citing paper
“In reality the positively skewed TSH distribution means that most individuals have a TSH between 0.4 and 3.0 mIU/L (Fig. 1) [15].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [15]
In the citing paper
“In older individuals on the other hand, the TSH distribution curve shifts to the right such that the upper TSH reference limit is as high as 7.0 mIU/L.”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [15]
In the citing paper
“Several large cross-sectional studies in iodine-replete thyroid disease-free populations have reported higher TSH concentrations in older individuals (Fig. 3), [15, 17, 87, 88].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [15]
In the citing paper
“These studies also show that the reference range becomes wider as age increases, with lower 2.5 centiles in the older age groups (Fig. 3).”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [15]
In the citing paper
“The National Health and Nutrition Examination Survey (NHANES) III reported an age-related increase in TSH with the 97.5 centile exceeding 7.0 mIU/L in individuals aged over 80 years [15, 87].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [15]
In the citing paper
“Moreover, we used both serum TSH and FT4 to define subclinical hypothyroidism, which has not been implemented in previous studies using NHANES III owing to the lack of FT4 data (ie, only total thyroxine data are available in NHANES III).5,29,44”
From Association of subclinical hypothyroidism and cardiovascular disease with mortality (2020) · cites this paper as [44]
In the citing paper
“However, this topic has taken on increasing significance, given that it has been recognized that up to 3% of older individuals have a serum TSH concentration that is below the healthy reference interval for younger people (subclinical hyperthyroidism), and approximately 10% have an elevated serum TSH level (subclinical hypothyroidism) (4–7).”
From Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study (2016) · cites this paper as [6]
In the citing paper
“Evidence from the US National Health and Nutrition Examination Survey (NHANES) found that about 4% of a population of community-dwelling subjects who were nominally free of thyroid dysfunction had evidence of occult autoimmune thyroid disease that increased the median TSH level and the upper reference limit for TSH [24, 51].”
From Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction (2019) · cites this paper as [24]
In the citing paper
“Increasing TSH with age was observed for both men and women in this study, while this and other studies have demonstrated higher levels of TSH in women than in men [14, 20, 23, 24].”
From Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction (2019) · cites this paper as [24]
In the citing paper
“A study from a large, nationally representative, population-based cohort in the USA found higher levels of TSH in non-Hispanic white vs. non-Hispanic black or Mexican American subjects [24].”
From Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction (2019) · cites this paper as [24]
In the citing paper
“There is less of a consensus regarding screening of the population for undiagnosed thyroid disease, which may be common among the general population.”
From Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction (2019) · cites this paper as [24]
In the citing paper
“For example, about 6% of subjects in the NHANES III cohort in the USA had evidence of undiagnosed thyroid disease [24].”
From Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction (2019) · cites this paper as [24]
In the citing paper
“Mild subclinical thyroid disease can progress at a low rate, suggesting a long-term screening program.”
From Thyroid dysfunction and diabetes mellitus: two closely associated disorders (2019) · cites this paper as [3]
In the citing paper
“disruption of PD-1/PD-L1 signaling induces diabetes in the non-obese diabetic (NOD) mouse model 71”
From Endocrine toxicities of immune checkpoint inhibitors (2021) · cites this paper as [71]
In the citing paper
“Similar to classic type 1 diabetes (T1D), ICI-DM is presumably caused by immune destruction of pancreatic beta cells.”
From Endocrine toxicities of immune checkpoint inhibitors (2021) · cites this paper as [71]
In the citing paper
“In a representative sample of U.S. subjects without known thyroid disease, 0.7% had suppressed TSH levels (<0.1 mU/L), and 1.8% had low TSH levels (<0.4 mU/L) (365).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [365]
In the citing paper
“In addition, mean serum TSH levels are lower in black non-Hispanic Americans, some of whom may have slightly low TSH levels without thyroid disease (365).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [365]
Citations
Cites
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
Tunbridge, W. M. G., Evered, D. C., Hall, R., Appleton, D. R., BREWIS, M., CLARK, F., Evans, J. G., Young, E. T., Bird, T., & Smith, P. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,665
The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey
Vanderpump, M. P. J., Tunbrldge, W. M. G., French, J. M., Appleton, D., Bates, D., Clark, F., Evans, J. G., Hasan, D. M., Rodgers, H., Tunbridge, F., et al. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01894.x · Cited by 2,432
Hak, A. E., Pols, H. A. P., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00004 · Cited by 1,336
SUDAAN User's Manual, Release 7.5,
Bieler, G. S., Barnwell, B., & Shah, B. V. (1997) · Cited by 1,273
American Thyroid Association guidelines for detection of thyroid dysfunction.
Ladenson, P., Singer, P., Ain, K., Bagchi, N., Bigos, S., Levy, E., Smith, S. A., Daniels, G., & Cohen, H. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.11.1573 · Cited by 658
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567
Hollowell, J. G., Staehling, N., Hannon, W. H., Flanders, D. W., Gunter, E. W., MABERLY, G. F., Braverman, L. E., Pino, S., Miller, D. T., Garbe, P. L., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5168 · Cited by 402
Self-citationLaurberg, P., Pedersen, K. M., Hreiðarsson, Á. B., Sigfússon, N., Iversen, E., & Knudsen, P. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4624 · Cited by 399
Screening for Thyroid Disease: An Update
Helfand, M., & Redfern, C. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00020 · Cited by 304
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S. M., Bien, C. G., Cellucci, T., Cortese, I. C. M., Dale, R. C., Gelfand, J. M., Geschwind, M. D., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,580
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“In addition, mean serum TSH levels are lower in black non-Hispanic Americans, some of whom may have slightly low TSH levels without thyroid disease (365).”
BackgroundJoglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,072
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Sherman, S. I., & Tuttle, R. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.109 · Cited by 2,014
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“LT3-only therapy should be monitored with measurements of fasting serum TSH levels before the administration of the dose, aiming to target serum TSH within the lower tertile of the reference range, if aiming for TSH values seen in a normal population (54).”
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
ESHRE Guideline: management of women with premature ovarian insufficiency
The ESHRE Guideline Group on POI, Webber, L. J., Davies, M. C., Anderson, R. A., Bartlett, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew027 · Cited by 1,603
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
State-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
Thyroid Function and Human Reproductive Health
Krassas, G. E., Poppe, K., & Glinoer, D. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0041 · Cited by 1,223
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216
The epidemiology of thyroid disease
Vanderpump, M. P. J. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr030 · Cited by 1,179
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Hashimoto thyroiditis: Clinical and diagnostic criteria
Caturegli, P., Remigis, A. D., & Rose, N. R. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.007 · Cited by 1,082
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
Iodine deficiency and thyroid disorders
Zimmermann, M. B., & Boelaert, K. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70225-6 · Cited by 930
Abalovich, M., Amino, N., Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Stagnaro‐Green, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0141 · Cited by 934
Sherma, S. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12488-9 · Cited by 926
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Pearce, E. N., Farwell, A. P., & Braverman, L. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021194 · Cited by 878
Self-citationDe Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Self-citation2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877
Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
The Incidence and Prevalence of Thyroid Dysfunction in Europe: A Meta-Analysis
Garmendia Madariaga, A., Santos Palacios, S., Guillén-Grima, F., & Galofré, J. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2409 · Cited by 800
Enewold, L., Zhu, K., Ron, E., Marrogi, A. J., Stojadinovic, A., Peoples, G. E., & Devesa, S. S. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0960 · Cited by 804
Surks, M. I., & Hollowell, J. G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1499 · Cited by 750
Self-citationLazarus, J., Brown, R. S., Daumerie, C., Hubalewska-Dydejczyk, A., Negro, R., & Vaidya, B. (2014) · European Thyroid Journal · doi:10.1159/000362597 · Cited by 742
Cooper, G. S., Bynum, M. L. K., & Somers, E. C. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.008 · Cited by 786
Thyroid hormones and cardiovascular disease
Jabbar, A., Pingitore, A., Pearce, S. H. S., Zaman, A., Iervasi, G., & Razvi, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.174 · Cited by 729
Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families
Alkhateeb, A. M., Fain, P. R., Thody, A. J., Bennett, D. C., & Spritz, R. A. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00032.x · Cited by 725
Osorio, J. C., Ni, A., Chaft, J. E., Pollina, R., Kasler, M. K., Stephens, D., Rodriguez, C., Cambridge, L., Rizvi, H., Wolchok, J. D., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw640 · Cited by 659
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M. C. D. O., Saraiva, J., Chacra, A., Bianco, H. T., Neto, A. A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A. C., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 690
Subclinical Hypothyroidism: A Review
Biondi, B., Cappola, A. R., & Cooper, D. S. (2019) · JAMA · doi:10.1001/jama.2019.9052 · Cited by 604
The incidence and prevalence of thyroid autoimmunity
McLeod, D. S. A., & Cooper, D. S. (2012) · Endocrine · doi:10.1007/s12020-012-9703-2 · Cited by 613
Thyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598
Roberts, C. G., & Ladenson, P. W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15696-1 · Cited by 567
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W. T., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 567
Golden, S. H., Robinson, K. A., Saldanha, I., Anton, B., & Ladenson, P. W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2291 · Cited by 542
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Chang, L., Barroso‐Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., & Min, L. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00006 · Cited by 550
Boelaert, K., Horáček, J., Holder, R. L., Watkinson, J. C., Sheppard, M. C., & Franklyn, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0527 · Cited by 532
Gencer, B., Collet, T.-H., Virgini, V., Bauer, D. C., Gussekloo, J., Cappola, A. R., Nanchen, D., den Elzen, W. P. J., Balmer, P., Luben, R. N., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096024 · Cited by 517
Iodine intake as a determinant of thyroid disorders in populations
Laurberg, P., Cerqueira, C., Ovesen, L., Rasmussen, L. B., Perrild, H., Andersen, S., Pedersen, I. B., & Carlé, A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.08.013 · Cited by 507
Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., & Bauer, D. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2460 · Cited by 503
Haymart, M. R., Repplinger, D., LEVERSON, G. E., Elson, D. F., Sippel, R. S., Jaume, J. C., & Chen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2215 · Cited by 496
Managing preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476
Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ochs, N., Auer, R., Bauer, D. C., Nanchen, D., Gussekloo, J., Cornuz, J., & Rodondi, N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00225 · Cited by 477
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 491
Updated assessment of the prevalence, spectrum and case definition of autoimmune disease
Hayter, S. M., & Cook, M. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.02.001 · Cited by 464
Hypothyroidism in Context: Where We’ve Been and Where We’re Going
Chiovato, L., Magri, F., & Carlé, A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01080-8 · Cited by 511
The Thyroid‐Brain Interaction in Thyroid Disorders and Mood Disorders
Bauer, M., Goetz, T., Glenn, T., & Whybrow, P. C. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01774.x · Cited by 441
Endocrine toxicities of immune checkpoint inhibitors
Wright, J. J., Powers, A. C., & Johnson, D. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00484-3 · Cited by 441
The Evidence for a Narrower Thyrotropin Reference Range Is Compelling
Wartofsky, L., & Dickey, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0455 · Cited by 424
Prevalence of hypothyroidism in adults: an epidemiological study in eight cities of India.
Unnikrishnan, A., Kalra, S., Sahay, R., Bantwal, G., John, M., & Tewari, N. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.113755 · Cited by 422
Tomer, Y., & Davies, T. F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0030 · Cited by 418
Golden, S. H., Brown, A., Cauley, J. A., Chin, M. H., Gary-Webb, T. L., Kim, C., Sosa, J. A., Sumner, A. E., & Anton, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2043 · Cited by 405
Hypothyroidism as a Risk Factor for Cardiovascular Disease
Biondi, B., & Klein, I. L. (2004) · Endocrine · doi:10.1385/endo:24:1:001 · Cited by 411
Gharib, H., Tuttle, R. M., Baskin, H. J., Fish, L. H., Singer, P. A., & McDermott, M. T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1231 · Cited by 394
Effects of Thyroid Dysfunction on Lipid Profile
Rizos, C. V., Elisaf, M., & Liberopoulos, E. N. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010076 · Cited by 411
Aoki, Y., Belin, R. M., Clickner, R., Jeffries, R., Phillips, L., & Mahaffey, K. R. (2007) · Thyroid · doi:10.1089/thy.2006.0235 · Cited by 390
Cooper, D. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14073-1 · Cited by 384
Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses
Jaslow, C. R., Carney, J. L., & Kutteh, W. H. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.166 · Cited by 382
Subclinical Hypothyroidism: An Update for Primary Care Physicians
Fatourechi, V. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.1.65 · Cited by 380
Lo, J. C.-M., Chertow, G. M., Go, A. S., & Hsu, C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00169.x · Cited by 372
Chronic urticaria and autoimmunity: Associations found in a large population study
Confino‐Cohen, R., Chodick, G., Shalev, V., Leshno, M., Kimhi, O., & Goldberg, A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.043 · Cited by 367
Subclinical Hyperthyroidism and Pregnancy Outcomes
Casey, B. M., Dashe, J. S., Wells, C. E., McIntire, D. D., Leveno, K. J., & Cunningham, F. G. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000197991.64246.9a · Cited by 358
Toi, Y., Sugawara, S., Sugisaka, J., Ono, H., Kawashima, Y., Aiba, T., Kawana, S., Saito, R., Aso, M., Tsurumi, K., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5860 · Cited by 352
Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening
Barker, J. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1679 · Cited by 350
Blount, B. C., Pirkle, J. L., Osterloh, J., Valentín-Blasini, L., & Caldwell, K. L. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9466 · Cited by 344
Subclinical Thyroid Dysfunction and Fracture Risk: A Meta-analysis
Blum, M. R., Bauer, D. C., Collet, T.-H., Fink, H. A., Cappola, A. R., da Costa, B. R., Wirth, C. D., Peeters, R. P., Åsvold, B. O., den Elzen, W. P. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.5161 · Cited by 343
Age-Related Changes in Thyroid Function: A Longitudinal Study of a Community-Based Cohort
Bremner, A. P., Feddema, P., Leedman, P. J., Brown, S. J., Beilby, J. P., Lim, E. M., Wilson, S. G., O'Leary, P. C., & Walsh, J. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3020 · Cited by 336
Excess iodine intake: sources, assessment, and effects on thyroid function
Rigutto‐Farebrother, J., Zimmermann, M. B., & Andersson, M. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14041 · Cited by 345
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Razvi, S., Shakoor, A., Vanderpump, M., Weaver, J. U., & Pearce, S. H. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0167 · Cited by 330
Thyroid Disorders and Diabetes Mellitus
Hage, M. P., Zantout, M. S., & Azar, S. T. (2011) · Journal of Thyroid Research · doi:10.4061/2011/439463 · Cited by 344
Selmer, C., Olesen, J. B., Hansen, M. L., Lindhardsen, J., Olsen, A.-M. S., Madsen, J. C., Faber, J., Hansen, P. R., Pedersen, O. D., Torp-Pedersen, C., et al. (2012) · BMJ · doi:10.1136/bmj.e7895 · Cited by 323
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
Lunenfeld, B., Mskhalaya, G. J., Zitzmann, M., Arver, S., Kalinchenko, S. Y., Tishova, Y. A., & Morgentaler, A. (2015) · The Aging Male · doi:10.3109/13685538.2015.1004049 · Cited by 318
Autoimmune Encephalitis Misdiagnosis in Adults
Flanagan, E. P., Geschwind, M. D., Lopez-Chiriboga, A. S., Blackburn, K. M., Turaga, S., Binks, S. N. M., Zitser, J., Gelfand, J. M., Day, G. S., Dunham, S. R., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.4251 · Cited by 311
Siegmann, E.-M., Müller, H. H. O., Luecke, C., Philipsen, A., Kornhuber, J., & Grömer, T. W. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0190 · Cited by 304
Thyroid autoimmunity and hypothyroidism before and during pregnancy
Poppe, K. G. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg012 · Cited by 309
Helfand, M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-2-200401200-00015 · Cited by 302
Fox, C. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.587 · Cited by 303
The role of thyroid autoimmunity in fertility and pregnancy
Poppe, K., Velkeniers, B., & Glinoer, D. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0846 · Cited by 298
Thyroid disease and female reproduction
Poppe, K. G., Velkeniers, B., & Glinoer, D. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02752.x · Cited by 310
Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges
Persani, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1616 · Cited by 295
Selmer, C., Olesen, J. B., Hansen, M. L., von Kappelgaard, L. M., Madsen, J. C., Hansen, P. R., Pedersen, O. D., Faber, J., Torp-Pedersen, C., & Gislason, G. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4184 · Cited by 288
Thyroid Function in Humans with Morbid Obesity
Michalaki, M. A., Vagenakis, A. G., Leonardou, A., Argentou, M. N., Habeos, I. G., Makri, M. G., Psyrogiannis, A. I., Kalfarentzos, F. E., & Kyriazopoulou, V. E. (2006) · Thyroid · doi:10.1089/thy.2006.16.73 · Cited by 295
The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives
Laurberg, P., Jørgensen, T., Perrild, H., Ovesen, L., Knudsen, N. J., Pedersen, I. B., Rasmussen, L. B., Carlé, A., & Vejbjerg, P. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02210 · Cited by 294
The Thyrotropin Reference Range Should Remain Unchanged
Surks, M. I., Goswami, G., & Daniels, G. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0170 · Cited by 287
Casey, B. M., & Leveno, K. J. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000244103.91597.c5 · Cited by 291
Metadata
- Authors
- Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E.
- Affiliations
- National Center for Environmental Health (US)
- Emory University (US)
- University of Southern California (US)
- Boston Medical Center (US)
- Corresponding author
- Hollowell, Joseph G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-02
- Volume
- 87
- Issue
- 2
- Pages
- 489-499
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1984273763
- Cited by
- 4,279
- References
- 41
- Citations by year
- 2026: 114 · 2025: 159 · 2024: 207 · 2023: 257 · 2022: 267 · 2021: 237 · 2020: 246 · 2019: 224 · 2018: 235 · 2017: 264 · 2016: 245 · 2015: 211 · 2014: 191 · 2013: 224 · 2012: 188
- FWCI
- 38.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- thyroid-stimulating hormone, serum thyroxine, thyroid peroxidase antibodies, thyroglobulin antibodies, thyroid autoantibodies, subclinical hypothyroidism, subclinical hyperthyroidism, reference values, sex differences, age differences, racial and ethnic differences, NHANES III, United States
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Autoantibodies, Black or African American, Demography, Female, Humans, Iodide Peroxidase, Iodine, Male, Middle Aged, Nutrition Surveys, Thyroglobulin, Thyrotropin, Thyroxine, Mexican Americans, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
